Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
Huntsman (HUN) Delivers +18% Revenue Growth in Third Quarter

Huntsman (HUN) Delivers +18% Revenue Growth in Third Quarter

Key Takeaways

  • Huntsman reported third quarter 2026 revenue of $1,717 million, up 18% year over year and above the consensus estimate of about $1,613 million.
  • Adjusted diluted earnings per share (EPS) came in at $0.04, below the roughly $0.06-to-$0.07 analyst consensus, while the GAAP diluted loss narrowed to $0.10 per share from $0.14 a year earlier.
  • Adjusted EBITDA rose 40% to $132 million, driven by gains in the Polyurethanes and Advanced Materials segments.
  • Free cash flow was $82 million, down from $157 million in the prior-year quarter, while liquidity held near $0.9 billion.
  • The pending merger of equals with Olin Corporation remains a central focus after shareholder approval in August 2026.

Earnings Context and Why It Matters

Huntsman’s third quarter results provide a useful checkpoint on the company’s cyclical recovery and its shift toward the planned merger with Olin Corporation. After a choppy first quarter influenced by Middle East tensions and higher feedstock costs, the firm has focused on pricing actions, cost cuts, and stronger demand in aerospace and power markets. For investors, the report helps clarify whether underlying operating profitability, as seen in adjusted EBITDA, is stabilizing even as headline numbers face pressure from elevated tax rates and restructuring items. The outcome also informs views on deleveraging, free cash flow trends, and the earnings potential of the combined entity once the merger closes.

Reported Results

For the third quarter ended September 30, 2026, HUN posted revenue of $1,717 million, an 18% increase from $1,460 million in the prior-year period and above the consensus estimate of about $1,613 million. Net loss attributable to Huntsman narrowed to $18 million from $25 million a year earlier, with a GAAP diluted loss per share of $0.10 versus $0.14 previously.

On an adjusted basis, the company reported net income of $7 million, or $0.04 per diluted share, up from an adjusted net loss of $5 million, or $0.03 per share, in the year-ago quarter. That adjusted figure fell short of analyst expectations of roughly $0.06 to $0.07 per share. Adjusted EBITDA climbed to $132 million from $94 million, reflecting stronger margins and volumes. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Segment performance was broadly positive. Polyurethanes revenue rose 21% and its adjusted EBITDA increased 56%, helped by higher MDI selling prices and volumes. Advanced Materials revenue rose 18%, with adjusted EBITDA up 41% on aerospace, automotive, and power demand. Performance Products revenue increased 6%, with adjusted EBITDA up 7%. Free cash flow was $82 million, down from $157 million a year earlier, while the company ended the quarter with roughly $0.9 billion in combined cash and unused borrowing capacity.

Market Reaction and Investor Sentiment

The market’s response to Huntsman’s report has been mixed, reflecting the contrast between a solid top-line beat and an adjusted earnings miss. Investors have welcomed the sharp year-over-year improvement in revenue and adjusted EBITDA as evidence that pricing and demand are recovering, particularly in Polyurethanes and Advanced Materials. At the same time, the shortfall on adjusted EPS, a high effective tax rate, and lighter free cash flow relative to last year have tempered enthusiasm. Broader sentiment also continues to hinge on progress toward the Olin merger, which shareholders approved in August 2026 and which is expected to reshape the company’s cost structure and market position.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be watching whether the pricing momentum in Polyurethanes and the volume strength in Advanced Materials can be sustained into 2027. Raw material costs, European energy prices, and inflation remain the most direct risks to margins, and any renewed volatility in those inputs could quickly reverse recent gains. From what I see, the merger with Olin Corporation is the dominant upcoming catalyst. The timing of completion, expected synergies, and the combined company’s capital allocation priorities will likely matter more to long-term shareholders than any single quarterly figure.

Balance sheet progress is another key monitor. Management has signaled an aim to reduce net debt leverage to roughly four times by year-end, supported by improving results and cash generation. Free cash flow recovery, capital expenditure discipline, and the trajectory of the adjusted tax rate will also be important indicators of how much earnings power ultimately converts into shareholder value.

Exploring Tickeron’s AI Tools

In preparing this analysis, I turned to Tickeron’s AI Screener to compare Huntsman’s performance against peers. It’s a useful tool for filtering based on fundamentals and patterns, allowing me to quickly surface comparable names in the chemicals space and review recent technical signals alongside the earnings data. The platform’s customizable filters help streamline the process of identifying relative strength or weakness without manual effort across hundreds of tickers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HUN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


HUN in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 30, 2026

HUN broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In 34 of the 42 cases the stock fell afterwards. This puts the odds of success at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HUN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for HUN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on HUN as a result. In 59 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for HUN just turned positive on October 15, 2026. Looking at past instances where HUN's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.

HUN moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where HUN advanced for three days, in 163 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.628) is normal, around the industry mean (1.207). P/E Ratio (-9.181) is within average values for comparable stocks, (3.806). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (3.769). Dividend Yield (0.036) settles around the average of (0.183) among similar stocks. P/S Ratio (0.269) is also within normal values, averaging (0.578).

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. HUN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Dow (NYSE:DOW).

Industry description

The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.

Market Cap

The average market capitalization across the Chemicals: Major Diversified Industry is 3.06B. The market cap for tickers in the group ranges from 80.4K to 67.31B. SHECF holds the highest valuation in this group at 67.31B. The lowest valued company is DEVV at 80.4K.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Major Diversified Industry was 4%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -25%. LXU experienced the highest price growth at 16%, while BAK experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Major Diversified Industry was 16%. For the same stocks of the Industry, the average monthly volume growth was 26% and the average quarterly volume growth was 0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 52
Price Growth Rating: 58
SMR Rating: 84
Profit Risk Rating: 87
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
HUN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of chemicals for the plastics, automotive and construction industries

Industry ChemicalsMajorDiversified

Industry
Chemicals Major Diversified
Address
10003 Woodloch Forest Drive
Phone
+1 281 719-6000
Employees
6000
Web
https://www.huntsman.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.
Huntsman (HUN) Delivers +18% Revenue Growth in Third Quarter